Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity
- PMID: 35609600
- PMCID: PMC9125827
- DOI: 10.1016/j.str.2022.04.014
Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity
Abstract
During RNA replication, coronaviruses require proofreading to maintain the integrity of their large genomes. Nsp14 associates with viral polymerase complex to excise the mismatched nucleotides. Aside from the exonuclease activity, nsp14 methyltransferase domain mediates cap methylation, facilitating translation initiation and protecting viral RNA from recognition by the innate immune sensors. The nsp14 exonuclease activity is modulated by a protein co-factor nsp10. While the nsp10/nsp14 complex structure is available, the mechanistic basis for nsp10-mediated modulation remains unclear in the absence of the nsp14 structure. Here, we provide a crystal structure of nsp14 in an apo-form. Comparative analysis of the apo- and nsp10-bound structures explain the modulatory role of the co-factor protein and reveal the allosteric nsp14 control mechanism essential for drug discovery. Further, the flexibility of the N-terminal lid of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nsp14 structure presented in this study rationalizes the recently proposed idea of nsp14/nsp10/nsp16 ternary complex.
Keywords: SAH; SARS-CoV-2; XRD; coronavirus; methylation; methyltransferase; nsp10; nsp14; proof-reading; structure.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures



Similar articles
-
Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity.Nucleic Acids Res. 2021 May 21;49(9):5382-5392. doi: 10.1093/nar/gkab320. Nucleic Acids Res. 2021. PMID: 33956156 Free PMC article.
-
Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex.Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9436-41. doi: 10.1073/pnas.1508686112. Epub 2015 Jul 9. Proc Natl Acad Sci U S A. 2015. PMID: 26159422 Free PMC article.
-
New insights into complex formation by SARS-CoV-2 nsp10 and nsp14.Nucleosides Nucleotides Nucleic Acids. 2024;43(8):798-812. doi: 10.1080/15257770.2024.2321600. Epub 2024 Feb 29. Nucleosides Nucleotides Nucleic Acids. 2024. PMID: 38422227
-
A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping.Cells. 2020 May 20;9(5):1267. doi: 10.3390/cells9051267. Cells. 2020. PMID: 32443810 Free PMC article. Review.
-
Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex.Molecules. 2022 May 3;27(9):2918. doi: 10.3390/molecules27092918. Molecules. 2022. PMID: 35566268 Free PMC article. Review.
Cited by
-
Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase.Nature. 2025 Jan;637(8048):1178-1185. doi: 10.1038/s41586-024-08320-0. Epub 2024 Dec 11. Nature. 2025. PMID: 39663451
-
Despite the odds: formation of the SARS-CoV-2 methylation complex.Nucleic Acids Res. 2024 Jun 24;52(11):6441-6458. doi: 10.1093/nar/gkae165. Nucleic Acids Res. 2024. PMID: 38499483 Free PMC article.
-
Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2.Sci Rep. 2024 Apr 29;14(1):9801. doi: 10.1038/s41598-024-58532-7. Sci Rep. 2024. PMID: 38684706 Free PMC article.
-
Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16.Molecules. 2024 May 15;29(10):2312. doi: 10.3390/molecules29102312. Molecules. 2024. PMID: 38792173 Free PMC article.
-
Going Retro, Going Viral: Experiences and Lessons in Drug Discovery from COVID-19.Molecules. 2022 Jun 14;27(12):3815. doi: 10.3390/molecules27123815. Molecules. 2022. PMID: 35744940 Free PMC article.
References
-
- Baddock H.T., Brolih S., Yosaatmadja Y., Ratnaweera M., Bielinski M., Swift L.P., Cruz-Migoni A., Fan H., Keown J.R., Walker A.P., et al. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification. Nucleic Acids Res. 2022;50:1484–1500. doi: 10.1093/nar/gkab1303. - DOI - PMC - PubMed
-
- Bouvet M., Imbert I., Subissi L., Gluais L., Canard B., Decroly E. RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex. Proc. Natl. Acad. Sci. U S A. 2012;109:9372–9377. doi: 10.1073/pnas.1201130109. - DOI - PMC - PubMed
-
- Devkota K., Schapira M., Perveen S., Khalili Yazdi A., Li F., Chau I., Ghiabi P., Hajian T., Loppnau P., Bolotokova A., et al. Probing the SAM binding site of SARS-CoV-2 Nsp14 in vitro using SAM competitive inhibitors guides developing selective bisubstrate inhibitors. SLAS Discov. 2021;26:1200–1211. doi: 10.1177/24725552211026261. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous